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Pannexin1 (Panx1) forms non-selective membrane channels, structurally similar to
gap junction hemichannels, and are permeable to ions, nucleotides, and other small
molecules below 900 Da. Panx1 activity has been implicated in paracrine signaling
and inflammasome regulation. Recent studies in different animal models showed that
overactivation of Panx1 correlates with a selective demise of several types of neurons,
including retinal ganglion cells, brain pyramidal, and enteric neurons. The list of Panx1
activators includes extracellular ATP, glutamate, high K+, Zn2+, fibroblast growth factors
(FGFs),pro-inflammatory cytokines, and elevation of intracellular Ca2+. Most of these
molecules are released following mechanical, ischemic, or inflammatory injury of the CNS,
and rapidly activate the Panx1 channel. Prolonged opening of Panx1 channel induced
by these “danger signals” triggers a cascade of neurotoxic events capable of killing
cells. The most vulnerable cell type are neurons that express high levels of Panx1.
Experimental evidence suggests that Panx1 channels mediate at least two distinct
neurotoxic processes: increased permeability of the plasma membrane and activation of
the inflammasome in neurons and glia. Importantly, both pharmacological and genetic
inactivation of Panx1 suppresses both these processes, providing a marked protection in
several disease and injury models. These findings indicate that external danger signals
generated after diverse types of injuries converge to activate Panx1. In this review we
discuss molecular mechanisms associated with Panx1 toxicity and the crosstalk between
different pathways.
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Connexin and pannexin families of channel proteins con-
nect cells to the environment by forming unpaired half-
channels (hemichannels) in the plasma membrane (Bennett and
Goodenough, 1978; Jones et al., 1997; Johnson and Owens,
1999). In contrast to gap junctions that mediate direct electri-
cal and metabolic coupling between cells (Goodenough et al.,
1980; Draguhn et al., 1998; Bennett and Zukin, 2004), hemichan-
nels support cell-environment communication and paracrine
signaling (Jones et al., 1997; Kumar et al., 2004). For example,
Pannexin1 (Panx1), which forms predominantly hemichannels,
was shown to be involved in paracrine signaling when activated
by ATP, UTP, and adenosine. In neurons, Panx1 hemichannels
are implicated in electrical communication (Iglesias and Spray,
2012), metabolic autocrine regulation (Kawamura et al., 2010),
short-term memory formation (Prochnow et al., 2012), regu-
lation of cell volume during high activity (Wurm et al., 2008,
2010; Li et al., 2012), proliferation and migration of neural stem
cells (Wicki-Stordeur et al., 2012), apoptotic “find me” signaling
(Chekeni et al., 2010; Sandilos et al., 2012) and possibly other
homeostatic functions.
It is known that, under conditions of stress and injury, neu-
ral cells rapidly decrease intercellular communication via gap
junctions and, instead, switch to hemichannels formed by either
connexins or pannexins that communicate with the environment
(Melov et al., 2007; Kim et al., 2008; Orellana et al., 2009). These
changes are likely modulated by growth factors, such as FGFs
(Reuss et al., 2000; Orellana et al., 2009; Garre et al., 2010).
Active involvement of hemichannels, particularly Panx1, has been
documented in various CNS and PNS pathologies, including
hippocampal neuron ischemia (Thompson et al., 2006), retinal
ischemia-reperfusion, in human spinal cord injury and throm-
boembolytic stroke, white matter ischemic injuries, spreading
depression, inflammatory enteric colitis, and pain formation (de
Rivero Vaccari et al., 2008; Zhang et al., 2008; Abulafia et al., 2009;
Domercq et al., 2010; Orellana et al., 2010; Bargiotas et al., 2011;
Dvoriantchikova et al., 2012b; Karatas et al., 2013). Experimental
data from both pharmacological blockade of the Panx1 channel
and genetic ablation of its gene supports a model where Panx1
activation is pivotal for facilitating selective neuronal demise in
these pathologies.
Interestingly, Panx1 expression level in retinal ganglion and
other neurons is at least 10 times lower than Cx36. However,
as indicated above genetic ablation or pharmacologic blockade
of Panx1, but not the Cx36 is profoundly neuroprotective in
the injured retina. In contrast, the deficiency in functional Cx36
has been liked to secondary degeneration following retinal injury
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(Striedinger et al., 2005). Taken together, the relatively low expres-
sion levels and profound effect of the knockout, indicate that
Panx1 activation is particularly neurotoxic (Bargiotas et al., 2011;
Dvoriantchikova et al., 2012b).
TOXICITY-ASSOCIATED PROPERTIES OF PANNEXIN-1
CHANNELS
Experimental evidence indicates that unique physiological prop-
erties of the Panx1 channel, including permeability to Ca2+,
ATP, and other small molecules contribute to the pathophysi-
ology of neuronal injury (Bao et al., 2004; Barbe et al., 2006;
Locovei et al., 2006a,b; Pelegrin and Surprenant, 2006; Thompson
et al., 2006). Unlike connexins, which are closed at physiological
concentrations of extracellular Ca2+ (Barbe et al., 2006), pan-
nexins remain open and can pass extracellular Ca2+ across the
plasma membrane (Vanden Abeele et al., 2006). Furthermore,
Panx1 hemichannels open in response to elevated intracellular
Ca2+ (Locovei et al., 2006b), contributing to a rapid post-injury
entry of extracellular Ca2+ into the cell (“calcium overload”)
following various injuries. Indeed, several studies showed that
Panx1 activation facilitates Ca2+ passage across the plasma mem-
brane (Vanden Abeele et al., 2006; Thompson et al., 2008;
Dvoriantchikova et al., 2012b; Weilinger et al., 2013) (Figure 1).
Another immediate consequence of a prolonged activation
of Panx1 channel is the efflux of ATP into the extracellu-
lar space (Bao et al., 2004; Reigada et al., 2008). Extracellular
ATP activates purinergic P2 receptors at the cellular surface,
induces IP3-mediated Ca2+ release from the endoplasmic retic-
ulum storage and downstream signaling cascades associated with
inflammation, and results in neurotoxicity. Compared with con-
nexin, pannexin hemichannels have superior permeability to
ATP, thus representing a major release pathway from stressed
or injured neurons and, possibly, glia (Iglesias et al., 2009;
Iglesias and Spray, 2012; Prochnow et al., 2012; Xia et al.,
2012; Dahl et al., 2013). That said, glial cells may also release
ATP via the Cx43 hemichannels, as shown by several investi-
gators (Saez et al., 2010; Orellana et al., 2011). This mecha-
nism, however, was questioned by others (Iglesias et al., 2009;
Suadicani et al., 2012) because ATP release was disrupted in
Panx1-null astrocytes but remained unaffected in Cx43-null
astrocytes. Therefore, it is reasonable to suggest that Panx1,
which is particularly abundant in several types of CNS neurons
(Bruzzone et al., 2003; Dvoriantchikova et al., 2006; Zoidl et al.,
2007), is directly responsible for the raise in extracellular ATP
and intracellular Ca2+, the two major events leading to CNS
injury.
In contrast to connexins, Panx1 can be activated by a broad
spectrum of extra- and intracellular stimuli. Many of these dan-
ger signals are released after injuries and in pathologies and
include (in addition to ATP) extracellular K+ and Zn2+, gluta-
mate, and pro-inflammatory cytokines. Within apoptotic cells,
Panx1 is irreversibly activated by proteolysis with caspases 3 and
7 (Bao et al., 2004; Barbe et al., 2006; Brough et al., 2009; Bunse
et al., 2009; Orellana et al., 2009; Chekeni et al., 2010). Panx1
is also mechanosensitive and opens by the stretch of the plasma
membrane that occurs during changes in osmolarity or mechani-
cal injuries. The result of a prolonged Panx1 activation is massive
influx of ions and small molecules into the cell and the efflux of
ATP and UTP, as schematically shown in Figure 1.
FUNCTIONAL INTERACTIONS WITH RECEPTORS AND
CHANNELS
Key interaction partners for Panx1 include surface receptors and
channels, which can be grouped by the following molecular con-
sequences: (i) interactions modulating intracellular Ca2+, which
include NMDA, P2X, and TRPV4 receptors; (ii) interactions with
Ca2+-mobilizing G protein-coupled receptors, such as P2Y and
PAR1 receptors that mobilize intracellular Ca2+ and activate PKC;
(iii) interactions leading toATP/ADP/adenosine signaling that also
include purinergic P2X receptors (P2XRs) (Figure 1). Available
data suggest that direct binding partners of Panx1 are P2XRs and
actin filaments. Functional modulators include NMDA, A1/A2
adenosine receptors, Kvβ3 potassium channels and fibroblast
growth factor-1 (FGF-1) (Bunse et al., 2009; Garre et al., 2010).
Currently, the most established mechanism of cell injury in
post-ischemic neurons is Ca2+ entry via ligand-gated channels,
such as NMDA receptor (NMDAR) and P2XRs (Lazarewicz et al.,
1990; Lobner and Lipton, 1993; Sucher et al., 1997; Franke
et al., 2006; Hardingham, 2009; Matute and Cavaliere, 2011).
However, recent studies indicated that these Ca2+ entry mech-
anisms are significantly facilitated by Panx1 channel activity
(Zhang et al., 2005a; Thompson et al., 2008; Orellana et al., 2011;
Gulbransen et al., 2012; Weilinger et al., 2013). Thus, according
to Thompson and co-authors, Panx1 opening is synergistic with
activation of NMDAR and can be facilitated by NMDA or gluta-
mate (Thompson et al., 2008; Weilinger et al., 2013). This group
also recently showed that both NMDAR antagonists, attenuated
currents carried by Panx1 and the SFK-Panx1 interfering peptide
significantly reduced anoxic depolarization, and Ca2+ influx in
OGD (Weilinger et al., 2012). According to their model, Panx1
activation occurs downstream of NMDAR and is mediated by
Src family kinases. If this model is correct, Ca2+ overload after
ischemic injury occurs via both NMDAR channel activity and the
opening of Panx1. Thus, extracellular glutamate is one of several
major pathological factors can facilitate Panx1overactivation and
the ensuing neurotoxicity.
Ca2+ can also enter cells via the purinergic P2XRs acti-
vated by extracellular ATP, and via transient receptor potential
vanilloid receptors (e.g., TRPV4) activated by mechanical stress
(Mochizuki et al., 2009; Ryskamp et al., 2011). Panx1 can facilitate
both these mechanisms to the point that transient extracellu-
lar Ca2+ changes are converted into the pathogenic overload.
Furthermore, ATP can be released via Panx1, further activating
P2XRs in paracrine or autocrine fashion (Figure 1). Functional
interaction between P2X7 receptor and Panx1 was first reported
to occur in macrophages by Pelegrin and Surprenant (2006), who
suggested on the basis of co-immunoprecipitation of ectopically
expressed Panx1 and P2XR isoforms that these two proteins can
interact directly. P2X7-dependent opening of the Panx1 channel
in response to ATP has been demonstrated in diverse pathological
settings, prompting researchers to name Panx1 “the pore-forming
unit of P2X7R-death complex” (Locovei et al., 2007; Iglesias et al.,
2008). In the CNS, a similar role was suggested for Panx1 complex
with P2X4R (de Rivero Vaccari et al., 2012), which is expressed
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FIGURE 1 | Schematic diagram of signaling mediated by surface
receptors and Panx1—in the injured retina in response to ischemia and
extracellular danger signals. Abbreviations: Glu, glutamate; DAMPs,
danger-associated molecular patterns; iCa2+, intercellular free calcium; TRPV,
transient receptor potential vanilloid, NMDAR, N-methyl-D-aspartate receptor;
P2XR, purinergic 2 receptor; TLR, Toll-like receptor, TNFR, tumor necrosis
factor receptor; HMGB1, high-mobility group protein B1; red arrows denote
activation pathways.
more abundantly than P2X7R in neurons of the spinal cord and
in retinal ganglion cells. Physical interaction between Panx1 and
P2XRs 2,3,4, and 7 were shown by co-immunoprecipitation in
rat pituitary cells (Li et al., 2011). Studies showed that Panx1-
mediated ATP release in certain cell types can also occur in
response to activation of metabotropic P2Y1 and P2Y2 receptors
(Locovei et al., 2006b; Zhang et al., 2012).
Interactions between TRPV4 channel and Panx1 hemichannel
were reported recently in the airway and ocular lens epithelium
(Seminario-Vidal et al., 2011; Shahidullah et al., 2012). These
results indicate that TRPV4 and associated Rho activity can trans-
duce cell membrane stretch to Panx1, which releases ATP (Iglesias
et al., 2008). As was suggested recently (Krizaj et al., 2013), this
novel model can provide feasible explanation for severe Ca2+
disregulation observed in retinal disorders linked to mechani-
cal stretch of the retina, such as intraocular pressure-induced
primary glaucoma. Importantly, TRPV4 activation was shown
to predispose RGCs to death via Ca2+-dependent pro-apoptotic
signaling pathways (Ryskamp et al., 2011). Additional binding
partners and modulators of Panx1 activity are A1 and A2 adeno-
sine receptors (Kawamura et al., 2010), Kvβ3 potassium channels
(Bunse et al., 2009), FGF-1 (Garre et al., 2010), actin microfila-
ments (Bhalla-Gehi et al., 2010; Bao et al., 2012), and thrombin-
specific protease-activated receptor 1 (PAR-1) (Godecke et al.,
2012). The significance of these recently detected interactions
remains to be determined.
Interestingly, in many cell types expressing P2XRs, receptor-
induced opening of the Panx1 channel is a relatively late event
that is preceded by the rapid opening of the receptor chan-
nel and occurs after a prolonged agonist application. Prior
to the discovery of pannexins, this delay was explained as a
slow development of a large pore via progressive dilation of
P2XRs themselves upon continuous/repetitive application of ago-
nist (Innocenti et al., 2004; Gourine et al., 2007). However,
later studies showed that Panx1 is required for generation of
the characteristic large current (∼500 pS) and permeability
to molecules up to 900Da (Pelegrin and Surprenant, 2006,
2009; Locovei et al., 2007; Iglesias et al., 2008). In the com-
plex with Panx1 channel, stimulation of P2XRs leads to sig-
nificantly higher currents compared to the activation of either
P2XRs, NMDAR, or TRPV4 alone. These experiments allowed
researchers to separate receptor activation and Panx1 open-
ing events (Iglesias et al., 2008). Physiologically, the delayed
Panx1 opening may provide for a tighter control of this large
cell-permeating pore, so that only abnormally high level of
activation would amplify Ca2+ uptake and ensuing neurotox-
icity (Locovei et al., 2007). Indeed, several lines of experi-
mental data indicate that ischemia-mediated Panx1 opening
also occurs 10–20min after the onset of ischemic conditions
(Thompson et al., 2006; Zhang et al., 2008; Dvoriantchikova et al.,
2012b; Weilinger et al., 2012). This delay could be attributed
to lagging development of conditions favoring Panx1 opening,
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such as anoxic depolarization and/or accumulation of agonists
(danger factors).
NEUROTOXIC SIGNALING MECHANISMS DOWNSTREAM OF
Panx1
What are the specific mechanisms of cell death downstream of
P2XR(4,7)–Panx1 complex? The most thoroughly studied mech-
anism involves intercellular ionic dysbalance, mostly Ca2+ over-
load and the subsequent activation of Ca2+-dependent proteases
including calpain and pro-apoptotic caspases (Dvoriantchikova
et al., 2012b; Paramo et al., 2013; Weilinger et al., 2013)
(Figure 1). The P2XR(4,7)–Panx1 complex has also been
reported to activate several enzymatic pathways known to damage
neuronal cells. The first one acts through the activation of ROS-
producing enzyme NADPH oxidase (Seil et al., 2008; Barakat
et al., 2012; Choi et al., 2012; Dvoriantchikova et al., 2012a). The
second mechanism links P2XR(4,7)–Panx1 overactivation with
a relatively new neurotoxic pathway, activation of the inflam-
masome (de Rivero Vaccari et al., 2012). Inflammasome is an
intracellular macromolecular complex responsible for proteolytic
processing and release of inflammatory interleukins IL-1β and
IL-18 (Pelegrin and Surprenant, 2006; Kanneganti et al., 2007).
Inflammasome was first characterized in macrophages and more
recently in glia and neurons (Silverman et al., 2009). Activation
of caspase-1, the principal component of the complex, was shown
to be dependent upon Panx1 in both neuronal and glial cell types
(Kanneganti et al., 2007; de Rivero Vaccari et al., 2009; Silverman
et al., 2009) but is redundant in macrophages (Pelegrin et al.,
2008; Qu et al., 2011). The role of inflammasome activation in
human pathologies those affecting the CNS have been extensively
reviewed elsewhere (Bernier, 2012; Dahl and Keane, 2012; Strowig
et al., 2012; Fleshner, 2013), here we will cover this topic very
briefly. Production of interleukins IL-1β and IL-18 depends on:
(1) transcriptional activation of the interleukin gene and accumu-
lation of the IL precursors; (2) proteolytic activation of caspase-1
within the inflammasome that is required to processes them into
mature forms.
The pathway for transcriptional activation of the IL-1β and
IL-18 genes requires activity of surface receptors, including
tumor necrosis factor (TNFR) and Toll-like (TLR) receptors, and
recruitment of the adapter protein MyD88, which is followed by
activation of transcription factor NF-κB (Figure 1) (de Rivero
Vaccari et al., 2008; Silverman et al., 2009). Parallel matura-
tion of cytokines appears to be a crucial step in the neurotoxic
pro-inflammatory program. This step requires Panx1 (Pelegrin
and Surprenant, 2007; Dvoriantchikova et al., 2012b), and is
independent on TLR activation (Kanneganti et al., 2007). The
inflammasome is rapidly activated in the CNS in sterile (non-
microbial) conditions in response to extracellular ATP and other
DAMPs (Maher, 2009; Lamkanfi, 2011; Ayna et al., 2012; Riteau
et al., 2012). It was also recently shown to be involved in the
release of the pro-inflammatory nuclear protein high-mobility
group B1 (HMGB1, or “alarmin”) (Karatas et al., 2013; Li et al.,
2013).
In the model of retinal ischemia-reperfusion, Panx1-mediated
neurotoxicity correlated with robust activation of endogenous,
neuronal inflammasome and the release of IL-1β in the ganglion
cell layer, the site of major damage (Dvoriantchikova et al.,
2012b). According to Pelegrin and co-authors, blocking the
Panx1 channels with siRNA, mimetic peptide or carbenox-
olone in macrophages prevented large pore formation, caspase-
1 activation, and processing/release of IL-1β (Pelegrin and
Surprenant, 2006; Pelegrin, 2008). The processing and release
of IL-1β in the post-ischemic retina are significantly attenu-
ated by Panx1 knockout (Bargiotas et al., 2011; Dvoriantchikova
et al., 2012b). Similarly, experimental blocking of the inflam-
masome in the CNS through pharmacological inactivation or
genetic ablation of either P2X7 receptor, Panx1, or any major
component of the inflammasome complex, including caspase-
1, NALP, or ASC proteins, had exactly same effect and simi-
lar degree of neuroprotection (Zhang et al., 2005a; Arai et al.,
2006; de Rivero Vaccari et al., 2009; Domercq et al., 2010).
Striking similarity in the degree of neuroprotection upon inac-
tivation of either Panx1 or inflammasome was observed in
mouse models of enteric colitis (Gulbransen et al., 2012).
Intriguingly, recent studies linked inflammasome activation
with the onset of pyroptosis, an inflammatory form of pro-
grammed cell death (Franchi et al., 2012; Strowig et al., 2012).
Another new non-apoptotic mechanisms of cell death that have
been recently linked with ischemic retinal and brain injury,
is necroptosis (Rosenbaum et al., 2010; Meloni et al., 2011).
However, despite the profile of Panx1-mediated neurotoxicity
matches that observed in necroptosis, no correlation between
Panx1 activity and necroptosis marker RIP3 has been reported
so far.
In addition to interleukin secretion, another pathway,
the inflammasome-dependent release of nuclear protein
alarmin/HMGB1 can facilitate neurotoxicity indirectly via glia-
mediated toxicity. This novel pathway has been recently
demonstrated in both inflammatory and neuronal cells
(Willingham et al., 2009; Lamkanfi et al., 2010). Initially
thought to be released from necrotic or injured cells, massive
HMGB1 release has been shown in live brain neurons affected by
spreading depression (Karatas et al., 2013), but the mechanism of
such release remains poorly characterized. The release of alarmin
from live cells is triggered by a spectrum of distinct cytokines
and/or danger signals produced during CNS stress or injury, and
is recently shown to be controlled by Panx1 (Yang et al., 2010;
Karatas et al., 2013). Furthermore, Karatas and coauthors showed
that alarmin binds to glial RAGE receptors leading to activation
of astroglial NF-κB pathway, which is one of the most potent
source of glial neurotoxicity in CNS disorders (Bales et al., 1998;
Brambilla et al., 2009, 2012; Dvoriantchikova et al., 2009; Barakat
et al., 2012).
The Panx1 channel can provide the gateway for
DAMPs/PAMPs to enter the cell and activate intracellular
TLRs, such as TLR3, which has been implicated in several
neurodegenerations, including glaucoma (Nowak and Davies,
2004; Zhang et al., 2005b; Shiose et al., 2011). These intracellular
TLRs receptors signal to NF-κB and are expressed by both
glial and microglial cells. These experiments demonstrated that
ATP-induced Panx1 channel opening provides an entry pathway
for bacterial danger signals into the cytosol, where they facilitated
the cryopyrin-dependent activation of caspase-1 (Kanneganti
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et al., 2007). When stimulated by ATP activation of P2X7R,
Panx1 was essential for proteolytic cleavage of caspase-1 and the
subsequent maturation and release of its substrate, IL-1β [24, 46,
47]. At the same time, the opening of Panx1 hemichannels was
shown to be independent of TLR activation [42], indicating that
Panx1 acts in parallel, not downstream of TLRs.
THE ROLE OF Panx1 IN NEUROTOXIC GLIA-NEURON
INTERACTIONS
How does activation of the ubiquitously expressed Panx1 result in
selective injury and death of distinct neuronal types? Such selec-
tive vulnerability is consistent with high levels of Panx1 expres-
sion in certain neuronal sub-populations, for example RGCs in
the retina and hippocampal pyramidal neurons (Dvoriantchikova
et al., 2006; Krizaj et al., 2013). An interesting model that pro-
posed a role of activated glia in triggering death of such sub-
populations was suggested by Orellana and co-authors. Using an
in vitro cell culture approach, they showed that neuronal demise
is triggered by synergistic action of high extracellular glutamate
and ATP on neuronal Panx1 channel (Orellana et al., 2011). The
mechanism of massive efflux of astroglial glutamate and ATP in
their model was initiated through the release of TNFα and IL-1β
cytokines from activated microglial cells. Additional studies are
required to test whether this mechanism of action occurs in vivo.
Our model summarizing mechanisms underlying Panx1-
mediated pathophysiology is depicted in Figure 1. As mentioned
above, Panx1 is activated by diverse signaling pathways. In patho-
logical conditions, Panx1 activation parallels transcriptional acti-
vation of the TLR-MyD88-NF-κB pathway to synergistically facil-
itate production and secretion of pro-inflammatory interleukins
IL-1β and IL-18. This model implies that transcriptional induc-
tion of MyD88-NF-κB by the upstream signaling requires syn-
chronization with activation of Panx1 to achieve a successful
cytokine release. Thus, activation of NF-kB-regulated gene tran-
scription downstream of Toll-like and TNF receptors occurs in
parallel with the activation of P2X receptors and Panx1, thereby
coordinating gene transcription with proteolytic processing of
interleukins.
PANX1 AS A PHARMACOLOGICAL TARGET
Blockers of Panx1 channel such as probenecid, mefloquine, and
carbenoxolone (Iglesias et al., 2008; Silverman et al., 2008) have
been used for several decades to treat gout, gastric ulcer and
infection diseases such as malaria (Doll et al., 1965; Trenholme
et al., 1975; Silverman et al., 2008). Unfortunately, these com-
pounds are not highly selective for Panx1 as they also block
other channels, including connexins. Side effects of these drugs
include pain, severe muscle weakness, mood changes, seizures,
psychiatric adverse reactions, and hypertension, which limits
their pharmacological potential. As an alternative, many labo-
ratories successfully utilized panx10 anti-peptide to block Panx1
function in experimental settings, however, specificity of this
reagent has also been disputed (Dahl, 2007). Development of new
Panx1 inhibitors with improved pharmacological characteristics
and selectivity will undoubtedly benefit investigators and physi-
cians looking to curb Panx1-mediated neurotoxicity in human
pathologies.
CONCLUSIONS
The unique properties of Panx1 channels contribute to the
profound neurotoxicity associated with this channel activation
during retinal and brain ischemia. The combination of high
permeability to ATP, ions, and other molecules, and activa-
tion by diverse injury-induced DAMPs, makes Panx1-expressing
neurons highly sensitive to mechanical and ischemia injuries.
Furthermore, Panx1 works synergistically with other neurotoxic
pathways, such as the TLR/TNF receptors-NF-κB axis facilitating
pro-inflammatory cytokine and HMGB1 in many cell types. The
involvement of Panx1 in multiple neurotoxic pathways, as well as
its proven “druggability” make it a promising target for therapies
of progressive neurodegenerations of the retina or brain.
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